Drug intelligence / Profile preview

qianlieweitong

Development stage
Unknown
Lead developer
Jilin Province Innovative Pharmaceutical Public Service Platform
Modality
Small Molecules
Administration
Oral
01

Overview

Qianlieweitong is a traditional Chinese medicine (TCM) formulation developed for the treatment of chronic prostatitis. It is primarily administered as an oral capsule. The drug was developed by the Jilin Province Innovative Pharmaceutical Public Service Platform Co., Ltd. and is designed to target the damp-heat and blood stasis syndrome, a common diagnostic category in TCM for patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). The formulation contains a mixture of herbal extracts, including *Astragalus membranaceus*, *Phellodendron chinense*, and *Paeonia lactiflora*, which are intended to provide anti-inflammatory, analgesic, and diuretic effects. Clinical development has reached Phase 3 in China, focusing on its ability to improve urinary symptoms and reduce pelvic pain in affected men.

Brand names
Qianlieweitong Granules
Other names
Qianlieweitong CapsulesQianlieweitong Jiaonang

Beyond the preview

Go deeper on qianlieweitong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qianlieweitong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call